Tirzepatide prescription online

Tirzepatide is the active ingredient in Mounjaro and Zepbound. Mounjaro was approved by the U.S. Food and Drug Administration (FDA) in 2022 to improve blood sugar (glucose) control in people with type 2 diabetes.

People taking Mounjaro also lost weight. So Mounjaro’s manufacturer, Eli Lilly, got Zepbound FDA-approved for weight loss in 2023. Zepbound and Mounjaro are the same medication, just approved for different uses. Zepbound is approved for people with a body mass index (BMI) of 30 or more, or people with a BMI of 27 or more and at least 1 weight-related health condition, such as type 2 diabetes, high cholesterol, or high blood pressure (hypertension).

In clinical trials, people who took 10 to 15 milligrams of Zepbound (tirzepatide) each week lost up to 20.9% of their body weight in 72 weeks. If you weigh 300 pounds, that’s a loss of more than 62 pounds! 

Whether you use compounded tirzepatide, Mounjaro, or Zepbound, you should eat a reduced-calorie diet and get more exercise.

You need a prescription from a healthcare provider to get a prescription for Zepbound, Mounjaro, or compounded tirzepatide, in-person or online. 

To get a prescription online, schedule an appointment with a licensed healthcare provider on Klarity Health. Your provider will assess your needs and help you develop a medical weight loss program that may includes medication, such as tirzepatide, if needed. 

When you choose a provider on Klarity Health, you can have an appointment in as little as 24 hours.*

If you and your provider decide that Zepbound, Mounjaro, or compounded tirzepatide is right for you, your provider can send your prescription to your pharmacy of choice.

Learn more about how to get tirzepatide in Zepbound.

If you take Zepbound (tirzepatide) or Mounjaro, the most common side effects include nausea, diarrhea, vomiting, constipation, stomach pain, indigestion, injection site reactions, fatigue, allergic reactions, belching, hair loss, and heartburn. Gastrointestinal side effects are most common, usually mild to moderate, and often go away or get less noticeable within a few weeks of first starting Zepbound or increasing your dose. 

Zepbound and Mounjaro can also have serious side effects, adverse reactions, and drug interactions. they have an FDA-boxed warning for the possibility of medullary thyroid carcinoma (or MTC, a type of thyroid cancer) or multiple endocrine neoplasia syndrome type 2 (MEN2). And some people shouldn’t take them or only take them with caution.

If you choose compounded tirzepatide, it may have the same or a different form of tirzepatide than Mounjaro or Zepbound. Side effects may be similar, but can be different. Compounded medications can be formulated with or without ingredients to prevent allergic reactions. Some compounded tirzepatide has added vitamin B12 to reduce side effects although there’s no research to support this.

Visit the tirzepatide side effects page to find all common side effects, serious side effects, adverse reactions, boxed warnings, and precautions. Talk to your healthcare provider or pharmacist too.

If you take a medication and have negative side effects, consider reporting them to the FDA by visiting MedWatch or calling 1-800-FDA-1088.